Aug 24, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Nedal Safwat has been appointed Chief Strategy Officer. Dr. Safwat joins Accelerate from BioMerieux, the world's leading...
Aug 18, 2020Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug...
Aug 6, 2020Accelerate Diagnostics Reports Second Quarter 2020 Financial Results & Announces New Product Offering
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2020. "While the progress of new contracts and go-lives continued to be slowed...
Jul 16, 2020
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern Time to review 2020 second quarter financial results. To...
May 7, 2020Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19...